Treatment of Sepsis in the ICU
Alan Lisbon, MD

Acting Chair, Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center
   
As Co-Director of the Surgical ICUs for the past 20 years, Dr Lisbon has been responsible for general administration, policy development, and quality of care within those units on both BIDMC campuses. During this time, the anesthesia critical care program at BIDMC has developed into one of the leading programs in the country.  Recent initiatives include the introduction of widespread use of echo and ultrasound technology in the ICU.   They have developed and instituted clinical guidelines for the ICUs over the past two years that have greatly lessened the incidence of iatrogenic infections, including reduction of central line infections and reduction of ventilator-associated pneumonia by 50 percent.   He has personally championed the development of a robust program in clinical research.

Currently, Dr Lisbon serves as Chair of the FDA panel on Anesthesia and Respiratory devices.   In addition, he has served as President of the New England Society of Critical Care and as a member of multiple national committees for the specialty.   His committee memberships include the Health, Science and Policy Committee for the ACCP, which is responsible for writing national guidelines on clinical care.